The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...

Roughly 2700 attendees heard a range of perspectives from experts in precision medicine, bioinformatics, and rare disease ...

Regeneron Pharmaceuticals will partner with Parabilis Medicines to discover and develop an initial five candidates ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

The CHOP's research team findings support the hypothesis that rare AAV integration can contribute to human oncogenesis, which ...

Biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific ...

Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...

AI scientists propose to automate the scientific method and accelerate drug discovery, where traditional timelines can span a ...